scispace - formally typeset
A

Adam R. Wende

Researcher at University of Alabama at Birmingham

Publications -  101
Citations -  6488

Adam R. Wende is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Heart failure & Mitochondrion. The author has an hindex of 33, co-authored 85 publications receiving 5252 citations. Previous affiliations of Adam R. Wende include Sanford-Burnham Institute for Medical Research & University of Utah.

Papers
More filters
Journal ArticleDOI

Diabetes-Related Cardiac Dysfunction

TL;DR: A review of mechanisms involving insulin resistance, dysregulation of microRNAs, and increased reactive oxygen species, as well as causes including both modifiable and non-modifiable risk factors, is published.
Journal ArticleDOI

Regulation of fatty acid metabolism by mTOR in adult murine hearts occurs independently of changes in PGC-1α

TL;DR: The role of rapamycin (mTOR) in the regulation of cardiac metabolism and mitochondrial respiration is not well established as discussed by the authors, but the role of mTOR in cardiac development, growth, and function is well established.
Journal ArticleDOI

My Sweetheart Is Broken: Role of Glucose in Diabetic Cardiomyopathy.

TL;DR: The unique contribution of glucose to heart disease and recent advances in defining mechanisms of action are discussed.
Journal ArticleDOI

Aberrant Water Homeostasis Detected by Stable Isotope Analysis

TL;DR: It is demonstrated that untreated diabetes mellitus results in distinct combinations, or signatures, of the hydrogen and oxygen isotope ratios in body water, and shows that the δ2H and δ18O values of body water are correlated with increased water flux, suggesting altered blood osmolality, due to hyperglycemia, as the mechanism behind this correlation.
Journal ArticleDOI

GLUT1 deficiency in cardiomyocytes does not accelerate the transition from compensated hypertrophy to heart failure

TL;DR: GLUT1 deficiency in cardiomyocytes alters myocardial substrate utilization, but does not substantially exacerbate pressure-overload induced contractile dysfunction or accelerate the progression to heart failure.